Open Access
CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1807033
ID: 635
Area: Neuroimmunology, multiple sclerosis and other demyelinating diseases
Presentation method: Eletronic Poster

Acute disseminated encephalomyelitis in a pediatric patient: case report

Juliana Coelho Xavier
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Carla Jéssica da Silva Fernandes
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Ezio Junio Gonçalves Nunes
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Renata Andrade Oliveira
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Madson do Nascimento Lopes
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Lázaro Inácio Araújo Rodrigues
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Francisco Monteiro Meneses
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Cinthya Maria Neves Varandas
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
,
Janeusa Rita Leite Primo Chagas
1   Obras Sociais Irmã Dulce, Salvador BA, Brazil.
› Author Affiliations
 

    *Correspondence: carlajessicasf@gmail.com.

    Abstract

    Case Presentation: This is an 8-year-old female child from Catu (BA). She presented symptoms that started in January/2023 of vomiting, myalgia and vertigo, evolving a few days later with fever, drowsiness and nystagmus. She presented with pharyngotonsillitis prior to the beginning of the reported symptoms. Due to suspicion of meningoencephalitis, antibiotic therapy (ceftriaxone) and antiviral therapy (acyclovir) was started and cerebrospinal fluid collection was performed, which was normal. Among the serologies collected, serology for cytomegalovirus (CMV) IgG reagent was evidenced. Magnetic resonance imaging (MRI) of the skull with alterations suggestive of acute disseminated encephalomyelitis (ADEM). Pulse therapy with methylprednisolone was performed for 3 days, with significant improvement of the condition and oral corticosteroids were maintained for 6 weeks, with good response. Currently, the patient has no complaints and a normal neurological examination.

    Discussion: ADEM is an acute, inflammatory and demyelinating disease of the central nervous system (CNS) with multifocal involvement, affecting the cerebral white matter and spinal cord. It has a rare incidence, with an expected rate for the pediatric age group. It is an autoimmune disease whose pathogenesis is still not fully understood. Clinical manifestations may arise after infections, either by viral agents, by bacteria, after vaccination or after the use of medications.

    Final Comments: Thus, the importance of ADEM as a differential diagnosis in pediatric neurology in patients with acute, progressive and severe symptoms is verified. This condition, when diagnosed early, has a better response to treatment and a better prognosis.


    Publication History

    Article published online:
    12 May 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil